Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Microfluidic EV Quantification for Point-of-Care CRC diagnostics

Project description

A new path for colorectal cancer diagnostics

Colorectal cancer (CRC) is a leading cause of cancer-related deaths, highlighting the urgent need for improved diagnostic methods. Supported by the Marie Skłodowska-Curie Actions programme, the μQuantEV project seeks to address this challenge by developing a groundbreaking platform that uses extracellular vesicles as biomarkers for CRC. This initiative combines advanced microfluidic technology with sophisticated analytical methods to facilitate the rapid and cost-effective detection of CRC-specific EVs. The project features a microfluidic EV enrichment module for capturing CRC-associated EVs and a fluorescence-based detection system for real-time analysis. With a strong focus on translational research and collaboration with clinical partners, μQuantEV aims to transform CRC diagnostics and advance personalised medicine, offering non-invasive screening alternatives.

Objective

The μQuantEV project aims to revolutionize the landscape of colorectal cancer (CRC) diagnostics through the development of a groundbreaking Point-of-Care (PoC) platform. Leveraging the emerging potential of extracellular vesicles (EVs) as robust biomarkers for CRC, this interdisciplinary endeavor combines cutting-edge microfluidic technology with advanced analytical methods to enable the sensitive, rapid, and cost-effective detection of CRC-specific EVs.
By designing, fabricating, and characterizing a microfluidic EV enrichment module, the project pioneers an innovative approach for the selective capture of CRC-associated EVs from patient-derived samples. Simultaneously, a state-of-the-art fluorescence-based EV detection and quantification module is developed to provide accurate and real-time analysis of the captured EVs. These two modules are seamlessly integrated to create a Lab-on-a-Chip diagnostic platform capable of detecting CRC at early stages with exceptional sensitivity and specificity.
Furthermore, μQuantEV places a strong emphasis on translational research, collaborating closely with clinical partners to validate the platform's performance using patient samples. The project also incorporates extensive open science practices to foster collaboration, transparency, dissemination of research outcomes.
Upon successful completion, the μQuantEV platform holds the potential to revolutionize CRC diagnostics, offering a cost-effective, non-invasive, and efficient alternative to current screening methods. Beyond CRC, the technology developed in this project can pave the way for the application of EV-based diagnostics in various other diseases, driving advancements in personalized medicine and improving healthcare outcomes.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

UNIVERSIDAD DE OVIEDO
Net EU contribution
€ 165 312,96
Address
CALLE SAN FRANCISCO 3
33003 OVIEDO
Spain
Region
Noroeste Principado de Asturias Asturias
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)